Hello and welcome to the details of Venezuela will not authorise AztraZeneca Covid-19 vaccine due to 'effects on patients', says VP and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
CARACAS, March 16 ― Venezuela will not authorise AstraZeneca's Covid-19 vaccine, Vice President Delcy Rodriguez said yesterday, citing unspecified “effects on patients.”
Rodriguez' comments came after several European countries paused inoculations using the vaccine following reports of blood coagulation in recipients. Other countries, including Canada and Australia, have continued to recommend its use.
Venezuela has so far used Russia's Sputnik V and China's Sinopharm in its vaccination programme.
The government had been in talks with political opposition ― recognised as the South American nation's legitimate interlocutors by many Western countries ― over a possible deal to participate in the World Health Organisation's (WHO) Covax initiative, which provides vaccines to poor countries.
While no deal has been reached so far, AstraZeneca supplies one of the main vaccines used in the Covax initiative.
Rodriguez also said she had met with a representative of the Pan-American Health Organisation to reiterate the government's demand that Britain release gold frozen in Venezuela's accounts in the country to facilitate payments for Covax vaccines. ― Reuters
These were the details of the news Venezuela will not authorise AztraZeneca Covid-19 vaccine due to 'effects on patients', says VP for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.